Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALXN | GSK | MRNA | ||
| Company | Alexion Pharm Inc | Gsk Plc ADR | Moderna Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 181.04 | 39.37 | 102.37 | ||
| High | 182.67 | 39.75 | 103.80 | ||
| Low | 180.13 | 39.37 | 101.13 | ||
| Last | 182.50 | 39.65 | 101.41 | ||
| Change | +3.05 | +0.38 | -0.59 | ||
| % Change | +1.70% | +0.97% | -0.58% | ||
| Volume | 90,506,096 | 818,366 | 1,011,801 | ||
| 20-Day Average Volume | 8,395,359 | 2,888,558 | 3,177,914 | ||
| Previous Close | 179.45 | 39.27 | 102.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 183.19 | 41.22 | 105.32 | ||
| 20-Day Raw Stochastic | 44.63% | 10.36% | 23.03% | ||
| 20-Day Relative Strength | 55.14% | 35.81% | 48.07% | ||
| Weighted Alpha | +62.81 | +9.12 | -20.49 | ||
| Today's Opinion | 72% Buy | 24% Buy | 72% Buy | ||
| Previous Opinion | 72% Buy | 24% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.87% since 07/13/21 | -2.61% since 04/12/24 | -3.60% since 04/12/24 | ||
| Low | 178.51 on 07/19/21 | 39.15 on 04/18/24 | 99.90 on 04/18/24 | ||
| High | 187.45 on 07/14/21 | 41.06 on 04/15/24 | 106.42 on 04/16/24 | ||
| 1-Month | |||||
| %Chg | +1.00% since 06/18/21 | -6.43% since 03/19/24 | -3.58% since 03/19/24 | ||
| Low | 178.51 on 07/19/21 | 39.15 on 04/18/24 | 97.00 on 04/03/24 | ||
| High | 187.45 on 07/14/21 | 43.45 on 03/25/24 | 115.89 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | +9.58% since 04/20/21 | -0.20% since 01/19/24 | +1.65% since 01/19/24 | ||
| Low | 164.83 on 04/29/21 | 38.56 on 01/25/24 | 84.06 on 02/13/24 | ||
| High | 187.45 on 07/14/21 | 43.84 on 03/07/24 | 115.89 on 04/09/24 | ||
| 6-Month | |||||
| %Chg | +15.70% since 01/20/21 | +11.90% since 10/19/23 | +23.04% since 10/19/23 | ||
| Low | 146.97 on 03/04/21 | 33.67 on 11/02/23 | 62.55 on 11/02/23 | ||
| High | 187.45 on 07/14/21 | 43.84 on 03/07/24 | 115.97 on 01/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 40,335,968 | 81,384,712 | 39,053,760 | ||
| Shares Outstanding, K | 221,019 | 2,072,440 | 382,880 | ||
| Annual Sales | 6,069,900,000 | 37,725,000,000 | 6,848,000,000 | ||
| Annual Net Income | 603,400,000 | 6,129,940,000 | -4,714,000,000 | ||
| Last Quarter Sales | 1,636,500,000 | 9,980,060,000 | 2,811,000,000 | ||
| Last Quarter Net Income | 636,000,000 | 433,200,000 | 217,000,000 | ||
| 60-Month Beta | 1.25 | 0.64 | 1.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 3.52 on 04/30/21 | 0.72 on 01/31/24 | 0.55 on 02/22/24 | ||
| Latest Earnings Date | 07/29/21 | 05/01/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | 0.397 on 02/22/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/22/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.07 | 10.29 | 0.00 | ||